# Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease

Study · id `cardio:ct-nct03635190` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03635190](<https://clinicaltrials.gov/study/NCT03635190>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03635190

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

## Technical summary

Registry record NCT03635190. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-17 (actual); primary completion 2021-03-24 (actual). Results posted on 2022-11-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Started: 2018-12-17 (actual) (ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Primary completion: 2021-03-24 (actual) (ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Completion: 2021-10-13 (actual) (ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Results first posted: 2022-11-04 (ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT03635190, source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03635190-2022-11-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
- Acronym: FASTII
- Condition: Peripheral Arterial Disease
- Intervention (Device): Orbital Circumferential Atherectomy
- Lead sponsor: Cardio Flow, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Libra Medical
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: c7412e1df23a459b60955d4c3f6008a8c8949f77025939cefee8adb0eacd5382
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
